Company / Cost of Revenue
Schrödinger, Inc. Cost of Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$113.3M
FY2025
5-year range
$36.5M / $113.3M
FY2021-FY2025
Trend
+50.1%
vs FY2024
Sector context
#89 of 113
Health Care
What the data says
Schrödinger, Inc.'s cost of revenue of $113M is lower than 79% of companies in the Health Care sector (FY2025). Increased from $76M to $113M over the past 2 years.
Based on SEC 10-K filings.
$113M in FY2025 with a 5-year CAGR of +25.5%.
Increased from $76M to $113M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +36.4%
- 5-Year CAGR
- +25.5%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 113This company $113.3M Sector average $11.3B
▼
-99.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.5%, indicating consistent growth.
- In FY2025, cost of revenue increased 50.1% year-over-year.
- Ranks #89 out of 113 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $113.3M | +50.1% |
| FY2024 | $75.5M | -0.7% |
| FY2023 | $76.0M | +70.3% |
| FY2022 | $44.6M | +22.4% |
| FY2021 | $36.5M | +0.0% |
| FY2020 | $36.5M | +0.0% |
| FY2019 | $36.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026